What will be shared, what will be learned at IPCU 2018?

What will be shared, what will be learned at IPCU 2018?

2017 saw the publication and dissemination of multiple new studies, including long-term results, and guidelines for prostate cancer treatment. Yet as the year passed by, we were surprised to discover that many clinicians remained unaware of the data and its ability to...

Prostate cancer survivor Dave Ricordati: “Do your own homework.”

  During Dave’s initial diagnosis for prostate cancer, his primary care physician and his urologist did not steer him toward brachytherapy. “Assuming you are not going to hear all of your options from your physician, and you are kind of on your own, then I always...

Isoray Patients Tell Their Stories

Herbert L https://fast.wistia.com/embed/medias/5owp14b3nk.jsonphttps://fast.wistia.com/assets/external/E-v1.js   During Herbert’s initial diagnosis for localized prostate cancer, his physician advised that he see a urologist. After having tests run at the Chicago...
Bringing Compassion and Hope to Cancer Patients

Bringing Compassion and Hope to Cancer Patients

The following article originally appeared in the Winter/Spring 2017 MicroCap Review Magazine. A small company in Richland, WA is dedicated to making a difference in the lives of patients diagnosed with different forms of cancer. Isoray Medical, Inc. [NYSE MKT:ISR] has...